Alnylam Pharmaceuticals
ALNY
#451
Rank
S$66.95 B
Marketcap
S$506.79
Share price
-4.85%
Change (1 day)
48.48%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: S$634.08 SGD on 2025-10-20

Lowest end of day price: S$5.10 SGD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Annual Stock Price Performance

Year Performance
2025 76.62%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
S$89.65-1.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$956.37-0.79%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.70-1.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.78-0.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.53 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
S$170.70-0.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$63.09 0.03%๐Ÿ‡ซ๐Ÿ‡ท France
S$38.32-1.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel